What Makes McKesson Corporation (MCK) an Attractive Bet?
TCW Funds, an investment management firm, published its first-quarter 2026 investor letter for the 'TCW Concentrated Large Cap Growth Fund.' A copy of the letter is available to download here.
Mckesson Corp (MCK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,312,164 | $1,135,494,239 | -5% | 0.61% |
| 2. | AQR Capital Management Cliff Asness | 907,472 | $784,246,271 | -2% | 0.36% |
| 3. | Lone Pine Capital Stephen Mandel | 392,224 | $339,414,961 | 2.71% | |
| 4. | SurgoCap Partners Mala Gaonkar | 348,732 | $301,778,724 | -17% | 10.08% |
| 5. | Farallon Capital Thomas Steyer | 234,300 | $202,753,848 | -22% | 1.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $144.52 | 692 | $100,006.66 | 6,843 | 2016-11-30 | Filing | |
| $136.36 | 100 | $13,635.52 | 2,005 | 2016-11-02 | Filing | |
| $136.35 | 900 | $122,715.00 | 1,905 | 2016-11-02 | Filing | |
| $156.21 | 1,000 | $156,211.40 | 1,000 | 2016-02-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $761.09 | 3,550 | $2,701,869.50 | 3,247 | 2026-05-26 | Filing | |
| $761.09 | 2,388 | $1,817,482.92 | 3,090 | 2026-05-26 | Filing | |
| $990.00 | 2,725 | $2,697,750.00 | 3,247 | 2026-03-02 | Filing | |
| $939.87 | 349 | $328,012.89 | 301 | 2026-02-19 | Filing | |
| $945.00 | 190 | $179,550.00 | 2,989 | 2026-02-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,418,384 | $9,881,012,634 | 0.17% | |
| 2. | 7,960,724 | $6,888,892,121 | 0.17% | |
| 3. | 5,731,756 | $4,964,698,395 | 0.17% | |
| 4. | 3,603,423 | $3,118,257,942 | 0.16% | |
| 5. | 3,268,340 | $2,811,394,547 | 0.18% |
News See All
McKesson Corporation (MCK) Highlights Resilience as Its Core Drug Distribution Network Stands the Test of Time
Eagle Point Capital, an investment firm, released its “Spring 2026 Portfolio Update" investor letter. A copy of the letter can be downloaded here.
McKesson Corporation (MCK) Surged 50% on Strong Earnings Growth and Resilient Drug Distribution Model
Latitude Investment Management, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
14 Best Dividend Stocks to Buy for Steady Growth
Investors looking for shelter from market volatility have been moving toward dividend stocks this year.
McKesson Corporation (NYSE:MCK) Q4 2026 Earnings Call Transcript
Operator: Welcome to McKesson's Fourth Quarter Fiscal 2026 Earnings Conference Call. Please be advised that today's conference is being recorded.
10 Best Large Cap Dividend Growth Stocks to Invest In
Dividends don’t always get much attention, but they’ve quietly driven a large share of long-term returns.
15 Cash-Rich Dividend Stocks to Invest In Right Now
On March 24, Reuters reported that Barclays raised its 2026 year-end S&P 500 target.
15 Best Consistent Dividend Stocks to Buy Right Now
According to an April 6 report by CNBC, if the Iran war drags on longer than expected, investors may want to look at defensive stocks that pay dividends, according to Jefferies.
Bank of America Sees Upside in McKesson (MCK) Biosimilar Push, Raises Target to $1,040
On March 6, Bank of America raised its price recommendation on McKesson Corporation (NYSE:MCK) to $1,040 from $970. It reiterated a Buy rating on the shares.
14 Best American Dividend Stocks to Invest In
Investors may face periods of market volatility in 2026. Adding dividend growth stocks could help bring some stability to portfolios.
Hedge Fund Resource Center